On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design

If you need an accessible version of this item, please submit a remediation request.
Date
2021-05
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Abstract

When comparing survival times of treatment and control groups under a more realistic nonproportional hazards scenario, the standard log-rank (SLR) test may be replaced by a more efficient weighted log-rank (WLR) test, such as the Fleming-Harrington (FH) test. Designing a group-sequential clinical trial with one or more interim looks during which a FH test will be performed, necessitates correctly quantifying the information fraction (IF). For SLR test, IF is defined simply as the ratio of interim to final numbers of events; but for FH test, it can deviate substantially from this ratio. In this article, we separate the effect of weight function (of FH test) alone on IF from the effect of censoring. We have shown that, without considering the effect of censoring, IF can be derived analytically for FH test using information available at the design stage and the additional effect due to censoring is relatively smaller. This article intends to serve two major purposes: first, to emphasize and rationalize the deviation of IF in weighted log-rank test from that of SLR test which is often overlooked (Jiménez, Stalbovskaya, and Jones); second, although it is impossible to predict IF for a weighted log-rank test at the design stage, our decomposition of effects on IF provides a reasonable and practically feasible range of IF to work with. We illustrate our approach with an example and provide simulation results to evaluate operating characteristics.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kundu, M. G., & Sarkar, J. (2021). On information fraction for Fleming‐Harrington type weighted log‐rank tests in a group‐sequential clinical trial design. Statistics in Medicine, 40(10), 2321–2338. https://doi.org/10.1002/sim.8905
ISSN
0277-6715, 1097-0258
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Statistics in Medicine
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}